Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

142 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Colesevelam HCl: a non-systemic lipid-altering drug.
Bays H, Dujovne C. Bays H, et al. Among authors: dujovne c. Expert Opin Pharmacother. 2003 May;4(5):779-90. doi: 10.1517/14656566.4.5.779. Expert Opin Pharmacother. 2003. PMID: 12740000 Review.
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.
Davidson MH, Stein EA, Hunninghake DB, Ose L, Dujovne CA, Insull W Jr, Bertolami M, Weiss SR, Kastelein JJ, Scott RS, Campod├│nico S, Escobar ID, Schrott HG, Bays H, Stepanavage ME, Wu M, Tate AC, Melino MR, Kush D, Mercuri M, Mitchel YB; Worldwide Expanded Dose Simvastatin Study Group. Davidson MH, et al. Among authors: dujovne ca. Nutr Metab Cardiovasc Dis. 2000 Oct;10(5):253-62. Nutr Metab Cardiovasc Dis. 2000. PMID: 11213534
Drug interactions with fibric acids.
Lozada A, Dujovne CA. Lozada A, et al. Among authors: dujovne ca. Pharmacol Ther. 1994 Aug;63(2):163-76. doi: 10.1016/0163-7258(94)90043-4. Pharmacol Ther. 1994. PMID: 7809177 Review.
142 results